Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. - Wikidata - wikimedia - TriplyDB

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

http://www.wikidata.org/entity/Q37639910

about

Selective use of sorafenib in the treatment of thyroid cancer What is the Minimal Surgery for Papillary Thyroid Carcinoma?The effect of neck dissection on quality of life in patients with differentiated thyroid cancer.Systematic review of clinical practice guidelines in the diagnosis and management of thyroid nodules and cancer Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastases.Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer.Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer.Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer.Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinoma.Optimal differentiated thyroid cancer management in the elderly.Nodal metastases in thyroid cancer: prognostic implications and management.Thyroid cancer surgery guidelines in an era of de-escalation.Impact of microscopic extra-nodal extension (ENE) on locoregional recurrence following curative surgery for papillary thyroid carcinoma.Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer.Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?Does undetectable basal Tg measured with a highly sensitive assay in the absence of antibodies and combined with normal ultrasonography ensure the absence of disease in patients treated for thyroid carcinoma?Response to sorafenib treatment in advanced metastatic thyroid cancer.Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems.Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer.Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.Follow-up of patients with thyroglobulin-antibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer.Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobuli The "broken chair" in patients with differentiated thyroid cancer.Follicular cell-derived thyroid cancer.Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma.Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH.Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.Biochemical persistence in thyroid cancer: is there anything to worry about?

P2860

Q26752891-4F462F8F-DF1B-4514-964D-849F6E0AB38B Q26765080-47020E89-D322-4288-8B2A-FD1F54306598 Q33973113-9952995D-11A1-4BA3-B554-7F922A65B3C5 Q34976377-FB4FEC43-DE6E-4524-8FE1-721CBE950FED Q35029676-4BA9B31E-BD17-4DD5-9D26-F23666B643BF Q35141951-A4A5920E-3093-4A00-986D-C4EA218F6D28 Q35165239-D96AF7CF-03B8-4180-BE08-F51FDF774B7A Q37178936-E0D4A550-9C15-4C63-9784-285B577B32D9 Q37404779-23799250-A9ED-4E06-999B-2A85F8ED4E8B Q38055493-153433FB-1AEC-4F56-A599-31487B91CB38 Q38396892-ABB810D5-7EF0-48E9-8D15-EEB76299D26E Q38763200-A4477520-30D2-4C09-88D1-217A657C13D7 Q39224958-2208217F-F4A6-44F1-ADAD-BC222F7D2059 Q40961909-6D3B3297-87F2-46A8-94B6-2287B60B831D Q41534942-3AAD939D-0E4F-435C-BF76-69689A3DE9F1 Q42427139-2B2D9CB2-AABF-4351-AFDA-7F8420EAA585 Q42482050-29E4822F-CB5F-4437-B524-03EF66663CAF Q42506361-651E2640-2E7E-4F0C-81B6-E07818B2B071 Q44062334-26A2AD58-959C-45E6-944D-520383F69EAC Q44448524-23267A93-DAA4-441E-A3BF-73CA416FED4F Q45760916-5A013832-82CE-47D0-9BA0-FCF37A55A20D Q47139487-B5887BA4-C0A3-452D-A9EA-875E1C128FC8 Q47164528-6D0BA17C-A513-4DEF-9AD0-C7D3876343B6 Q47371766-C75BBC71-65F6-4736-A5DF-B6AD18C8E5F1 Q48096442-680C9E08-84D3-44A0-B27C-41E44CE725D5 Q48274461-52449A12-D0ED-486B-B333-D5BD0623D20A Q48651339-FA96C8F2-D670-456A-A728-019714F082D4 Q50876535-A371781C-F511-48FA-BD3B-0DFF4D0D05C3 Q51477265-5E08ADB5-6CC6-49E1-BE00-657CF5E28EFD Q51719980-B03A9F4C-78E6-4FE3-9EA9-800FA146F978 Q54519715-BF5CAB92-9ED7-449B-90C0-146856A15F9F

P2860

Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer.

http://www.wikidata.org/entity/Q37639910

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recommendations of the Latin A ...... differentiated thyroid cancer.

@en

Recommendations of the Latin A ...... differentiated thyroid cancer.

@nl

type

label

Recommendations of the Latin A ...... differentiated thyroid cancer.

@en

Recommendations of the Latin A ...... differentiated thyroid cancer.

@nl

prefLabel

Recommendations of the Latin A ...... differentiated thyroid cancer.

@en

Recommendations of the Latin A ...... differentiated thyroid cancer.

@nl

P1433

Q37639910-22390030-91BD-4099-8213-4715637BAE4D

P1476

Q37639910-3E5BD7DE-8186-4EB3-8317-45E3AEB5EAE3

P2093

Q37639910-0217C699-CF2F-4419-9655-F8DAD144CC9A

Q37639910-230BFB34-1372-433D-A6C9-D90C511FCC6F

Q37639910-5E251453-C0DB-4468-8C62-CFD5A11DCF76

Q37639910-7785475B-0FC5-49EF-9347-1ABF9F51FD02

Q37639910-78C1622A-752F-4103-8CFC-895C12821AFC

Q37639910-7BB4910C-C585-4DE0-ACF3-D3EDF7DEDE84

Q37639910-7BE69AB2-8000-4DA1-BE03-B2A9A6FFF422

Q37639910-8FFCA1BE-81F5-42A8-86D1-49862F8597B5

Q37639910-D5499DE3-4F9F-4DB8-BFD9-1361B87597E9

Q37639910-EB2CBD48-DBAD-4369-94F4-15EA3C317C71

P2860

Q37639910-0825DC6A-5129-429D-A9E6-FEACBC045ADF

Q37639910-0B2EC74A-2DE7-4A33-BDF8-BC243B204AC8

Q37639910-103B6C1D-8FB2-4D99-9965-257D47A18C0C

Q37639910-1DA57059-456B-4386-800F-2C123352582F

Q37639910-2953E383-4435-4502-BF93-0FA8AE42422D

Q37639910-36442196-6505-4709-B981-E6A487DC9D26

Q37639910-47672CCC-E826-424B-BA04-EBDB94128A38

Q37639910-4C47BAC0-B1A9-4091-8424-2F590430D2D3

Q37639910-504C8D6B-AA8E-457B-9AF5-F13CD33B4168

Q37639910-52FA30D7-BBE3-4AB2-8C2B-D6D62643BD94

P304

Q37639910-469AC66A-839C-4122-9A29-BEAF7278A0EB

P31

Q37639910-FADD7DF6-23EF-41EA-AE6F-60FBEDD9904B

P356

Q37639910-10E2C390-8CEF-4075-AFE9-5C594FE43F5C

P433

Q37639910-F09E463A-7BC6-4775-A05F-D8B21E56A249

P478

Q37639910-9CF8B1AA-4ED3-4DE4-801D-174222B42209

P50

Q37639910-BB63B154-31DB-4FB2-B7D5-6162B35F87CA

P577

Q37639910-FB6FA228-42AC-4383-9DB0-96E9FDF17CE6

P698

Q37639910-72553957-C28E-43E2-ABB6-6AC1F5B6EB24

P921

Q37639910-090fcc28-0b0a-4430-b2da-36e8dd791604

P356

S0004-27302009000700014

P1433

Arquivos Brasileiros de Endocrinologia e Metabologia

P1476

Recommendations of the Latin A ...... differentiated thyroid cancer

@en

P2093

Alicia Gauna

http://www.w3.org/2001/XMLSchema#string

Celso Friguglietti

http://www.w3.org/2001/XMLSchema#string

Eduardo Pretell

http://www.w3.org/2001/XMLSchema#string

Eduardo Tomimori

http://www.w3.org/2001/XMLSchema#string

Fernando Munizaga

http://www.w3.org/2001/XMLSchema#string

Hugo Niepomniszcze

http://www.w3.org/2001/XMLSchema#string

Laura Ward

http://www.w3.org/2001/XMLSchema#string

Mario Vaisman

http://www.w3.org/2001/XMLSchema#string

Nelson Wohllk

http://www.w3.org/2001/XMLSchema#string

Rosalinda Camargo

http://www.w3.org/2001/XMLSchema#string

P2860

Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity.

Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.

Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.

Phase II trial of sorafenib in advanced thyroid cancer.

Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.

Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?

131I therapy for elevated thyroglobulin levels.

P304

884-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0004-27302009000700014

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19942992

http://www.w3.org/2001/XMLSchema#string

P921